94 related articles for article (PubMed ID: 22766316)
1. Preclinical efficacy of THRX-200495, a dual pharmacology muscarinic receptor antagonist and β(2)-adrenoceptor agonist (MABA).
McNamara A; Steinfeld T; Pulido-Rios MT; Stangeland E; Hegde SS; Mammen M; Martin WJ
Pulm Pharmacol Ther; 2012 Oct; 25(5):357-63. PubMed ID: 22766316
[TBL] [Abstract][Full Text] [Related]
2. Pharmacologic characterization of GSK-961081 (TD-5959), a first-in-class inhaled bifunctional bronchodilator possessing muscarinic receptor antagonist and β2-adrenoceptor agonist properties.
Hegde SS; Hughes AD; Chen Y; Steinfeld T; Jasper JR; Lee TW; McNamara A; Martin WJ; Pulido-Rios MT; Mammen M
J Pharmacol Exp Ther; 2014 Oct; 351(1):190-9. PubMed ID: 25100753
[TBL] [Abstract][Full Text] [Related]
3. THRX-198321 is a bifunctional muscarinic receptor antagonist and beta2-adrenoceptor agonist (MABA) that binds in a bimodal and multivalent manner.
Steinfeld T; Hughes AD; Klein U; Smith JA; Mammen M
Mol Pharmacol; 2011 Mar; 79(3):389-99. PubMed ID: 21139051
[TBL] [Abstract][Full Text] [Related]
4. Application of the classical Einthoven model of bronchoconstriction to the study of inhaled bronchodilators in rodents.
McNamara A; Pulido-Rios MT; Hegde SS; Martin WJ
J Pharmacol Toxicol Methods; 2011; 63(1):89-95. PubMed ID: 20594937
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological preclinical characterization of LAS190792, a novel inhaled bifunctional muscarinic receptor antagonist /β
Aparici M; Carcasona C; Ramos I; Montero JL; Ortiz JL; Cortijo J; Puig C; Vilella D; Doe C; Gavaldà A; Miralpeix M
Pulm Pharmacol Ther; 2017 Oct; 46():1-10. PubMed ID: 28729041
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological Profile of AZD8871 (LAS191351), a Novel Inhaled Dual M
Aparici M; Carcasona C; Ramos I; Montero JL; Otal R; Ortiz JL; Cortijo J; Puig C; Vilella D; De Alba J; Doe C; Gavaldà A; Miralpeix M
J Pharmacol Exp Ther; 2019 Jul; 370(1):127-136. PubMed ID: 31085697
[TBL] [Abstract][Full Text] [Related]
7. In vivo pharmacological characterization of TD-4208, a novel lung-selective inhaled muscarinic antagonist with sustained bronchoprotective effect in experimental animal models.
Pulido-Rios MT; McNamara A; Obedencio GP; Ji Y; Jaw-Tsai S; Martin WJ; Hegde SS
J Pharmacol Exp Ther; 2013 Aug; 346(2):241-50. PubMed ID: 23685545
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of AZD9708, a novel, selective β2-adrenoceptor agonist with rapid onset and long duration of action.
Nicholls DJ; Jordan S; Cadogan E; Lawson M; Austin RP; Paine SW; Gardiner P; Bonnert R; Connolly S; Young A
Pulm Pharmacol Ther; 2012 Aug; 25(4):293-302. PubMed ID: 22659538
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological characterization of abediterol, a novel inhaled β(2)-adrenoceptor agonist with long duration of action and a favorable safety profile in preclinical models.
Aparici M; Gómez-Angelats M; Vilella D; Otal R; Carcasona C; Viñals M; Ramos I; Gavaldà A; De Alba J; Gras J; Cortijo J; Morcillo E; Puig C; Ryder H; Beleta J; Miralpeix M
J Pharmacol Exp Ther; 2012 Aug; 342(2):497-509. PubMed ID: 22588259
[TBL] [Abstract][Full Text] [Related]
10. Discovery of muscarinic acetylcholine receptor antagonist and beta 2 adrenoceptor agonist (MABA) dual pharmacology molecules.
Hughes AD; Chin KH; Dunham SL; Jasper JR; King KE; Lee TW; Mammen M; Martin J; Steinfeld T
Bioorg Med Chem Lett; 2011 Mar; 21(5):1354-8. PubMed ID: 21310610
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo preclinical profile of abediterol (LAS100977), an inhaled long-acting β2-adrenoceptor agonist, compared with indacaterol, olodaterol and vilanterol.
Aparici M; Gavaldà A; Ramos I; Carcasona C; Otal R; Fernández-Blanco JA; Montero JL; García VM; López R; De Alba J; Doe C; Puig C; Vilella D; Miralpeix M
Eur J Pharmacol; 2016 Jan; 770():61-9. PubMed ID: 26656755
[TBL] [Abstract][Full Text] [Related]
12. Discovery of a novel class of inhaled dual pharmacology muscarinic antagonist and β
Rancati F; Linney ID; Rizzi A; Delcanale M; Knight CK; Schmidt W; Pastore F; Riccardi B; Mileo V; Carnini C; Cesari N; Blackaby WP; Patacchini R; Carzaniga L
Bioorg Med Chem Lett; 2021 Jun; 41():127975. PubMed ID: 33753262
[TBL] [Abstract][Full Text] [Related]
13. Multivalent dual pharmacology muscarinic antagonist and β₂ agonist (MABA) molecules for the treatment of COPD.
Hughes AD; McNamara A; Steinfeld T
Prog Med Chem; 2012; 51():71-95. PubMed ID: 22520472
[No Abstract] [Full Text] [Related]
14. Discovery of (R)-1-(3-((2-chloro-4-(((2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethyl)amino)methyl)-5-methoxyphenyl)amino)-3-oxopropyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate (TD-5959, GSK961081, batefenterol): first-in-class dual pharmacology multivalent muscarinic antagonist and β₂ agonist (MABA) for the treatment of chronic obstructive pulmonary disease (COPD).
Hughes AD; Chen Y; Hegde SS; Jasper JR; Jaw-Tsai S; Lee TW; McNamara A; Pulido-Rios MT; Steinfeld T; Mammen M
J Med Chem; 2015 Mar; 58(6):2609-22. PubMed ID: 25629394
[TBL] [Abstract][Full Text] [Related]
15. Use of propranolol blockade to explore the pharmacology of GSK961081, a bi-functional bronchodilator, in healthy volunteers: results from two randomized trials.
Norris V; Ambery C
Drugs R D; 2014 Dec; 14(4):241-51. PubMed ID: 25265895
[TBL] [Abstract][Full Text] [Related]
16. Dual-pharmacology muscarinic antagonist and β₂ agonist molecules for the treatment of chronic obstructive pulmonary disease.
Hughes AD; Jones LH
Future Med Chem; 2011 Oct; 3(13):1585-605. PubMed ID: 21942250
[TBL] [Abstract][Full Text] [Related]
17. Prevention of bronchoconstriction in sensitized guinea pigs: efficacy of common prophylactic drugs.
Schütz N; Peták F; Barazzone-Argiroffo C; Sly PD; Habre W
Respir Physiol Neurobiol; 2004 Jul; 141(2):167-78. PubMed ID: 15239967
[TBL] [Abstract][Full Text] [Related]
18. Characterization of aclidinium bromide, a novel inhaled muscarinic antagonist, with long duration of action and a favorable pharmacological profile.
Gavaldà A; Miralpeix M; Ramos I; Otal R; Carreño C; Viñals M; Doménech T; Carcasona C; Reyes B; Vilella D; Gras J; Cortijo J; Morcillo E; Llenas J; Ryder H; Beleta J
J Pharmacol Exp Ther; 2009 Nov; 331(2):740-51. PubMed ID: 19710368
[TBL] [Abstract][Full Text] [Related]
19. Low-dose salbutamol suppresses airway responsiveness to histamine but not methacholine in subjects with asthma.
Matsumoto K; Aizawa H; Fukuyama S; Yoshida M; Komori M; Takata S; Koto H; Inoue H
Respir Investig; 2013 Sep; 51(3):158-65. PubMed ID: 23978642
[TBL] [Abstract][Full Text] [Related]
20. In vitro anti-inflammatory effects of AZD8999, a novel bifunctional muscarinic acetylcholine receptor antagonist /β2-adrenoceptor agonist (MABA) compound in neutrophils from COPD patients.
Milara J; Contreras S; de Diego A; Calbet M; Aparici M; Morcillo E; Miralpeix M; Cortijo J
PLoS One; 2019; 14(1):e0210188. PubMed ID: 30608978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
